www.fdanews.com/articles/123047-cell-therapeutics-8217-pixantrone-to-be-reviewed-by-fda
Cell Therapeutics’ Pixantrone to Be Reviewed by FDA
December 17, 2009
Cell Therapeutics, Inc. announced Thursday that on February 10, 2010 the U.S.
Food and Drug Administration’s Oncologic Drugs Advisory Committee
will review the New Drug Application for pixantrone for the treatment of relapsed/refractory aggressive non-Hodgkin’s lymphoma.
StreetInsider
StreetInsider